Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2004-5-20
pubmed:abstractText
The neuroligins are a family of postsynaptic transmembrane proteins that associate with presynaptic partners, the beta-neurexins. Neurexins and neuroligins play a critical role in initiating formation and differentiation of synaptic junctions. A recent study reported that a mutation of neuroligin-3 (NL3), an X-linked gene, was found in siblings with autistic spectrum disorder in which two affected brothers had a point mutation that substituted a Cys for Arg451. To characterize the mutation at the biochemical level, we analyzed expression and activity of the mutated protein. Mass spectrometry comparison of the disulfide bonding pattern between the native and the mutated proteins indicates the absence of aberrant disulfide bonding, suggesting that the secondary structure of the mutated protein is conserved. However, the mutation separately affects protein expression and activity. The Cys mutation causes defective neuroligin trafficking, leading to retention of the protein in the endoplasmic reticulum. This, in turn, decreases the delivery of NL3 to the cell surface. Also, the small fraction of protein that reaches the cell membrane lacks or has markedly diminished beta-neurexin-1 (NX1beta) binding activity. Other substitutions for Arg451 allow for normal cellular expression but diminished affinity for NX1beta. Our findings reveal a cellular phenotype and loss of function for a congenital mutation associated with autistic spectrum disorders.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
19
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4889-93
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15152050-Amino Acid Substitution, pubmed-meshheading:15152050-Animals, pubmed-meshheading:15152050-Autistic Disorder, pubmed-meshheading:15152050-Cell Adhesion Molecules, Neuronal, pubmed-meshheading:15152050-Cell Line, pubmed-meshheading:15152050-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:15152050-Fluorescent Antibody Technique, pubmed-meshheading:15152050-Gene Expression, pubmed-meshheading:15152050-Humans, pubmed-meshheading:15152050-Immunoblotting, pubmed-meshheading:15152050-Mass Spectrometry, pubmed-meshheading:15152050-Membrane Proteins, pubmed-meshheading:15152050-Mutation, pubmed-meshheading:15152050-Nerve Tissue Proteins, pubmed-meshheading:15152050-Protein Binding, pubmed-meshheading:15152050-Protein Processing, Post-Translational, pubmed-meshheading:15152050-Rats, pubmed-meshheading:15152050-Recombinant Fusion Proteins, pubmed-meshheading:15152050-Sequence Deletion, pubmed-meshheading:15152050-Solubility, pubmed-meshheading:15152050-Surface Plasmon Resonance, pubmed-meshheading:15152050-Transfection
pubmed:year
2004
pubmed:articleTitle
The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing.
pubmed:affiliation
Department of Pharmacology, University of California, San Diego, La Jolla, California 92093-0636, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.